Comorbidities Resolution After MGB Surgery and Change in Body Composition
Launched by ALL INDIA INSTITUTE OF MEDICAL SCIENCES, BHUBANESWAR · Aug 23, 2023
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how Mini-Gastric Bypass (MGB) surgery can help improve health problems related to obesity, such as diabetes, sleep apnea, and high blood pressure. The researchers want to see how changes in body weight and composition after the surgery are related to the improvement of these conditions. Participants will be people aged between 18 and 75 who are scheduled to have MGB surgery for their obesity and its related health issues.
If you or a loved one qualifies and chooses to participate, you will undergo the MGB surgery as usual, and there won’t be any extra treatments or procedures just for the study. The team will monitor your health after the surgery to understand how well it works for improving your weight and related medical problems. It's important to note that if someone has previously had a similar surgery or does not agree to participate, they won't be included in this study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients undergoing laparoscopic MGB surgery for morbid obesity and it's associated comorbidities
- Exclusion Criteria:
- • Patients not giving consent for the study
- • All patients who were undergoing a redo-procedure for recurrence were excluded from the study
About All India Institute Of Medical Sciences, Bhubaneswar
The All India Institute of Medical Sciences (AIIMS), Bhubaneswar, is a premier medical research and educational institution dedicated to advancing healthcare through innovative clinical trials and research initiatives. Established to provide high-quality medical education and comprehensive patient care, AIIMS Bhubaneswar focuses on developing cutting-edge treatments and therapies to address pressing health challenges in India and beyond. With a commitment to ethical research practices and collaboration with national and international partners, AIIMS Bhubaneswar plays a pivotal role in enhancing medical knowledge and improving patient outcomes through evidence-based practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bhubaneswar, Odisha, India
Patients applied
Trial Officials
Prakash K Sasmal, MS, FACS
Principal Investigator
All India Institute of Medical Sciences, Bhubaneswar, India
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported